What should we leave behind, if we cannot leave nothing behind?
A primary ”leave-nothing-behind” approach is favored by many physicians in the treatment of femoropopliteal PAD. It remains, however, unclear which is the best treatment option when we have to leave ”something” behind. In this case the Eluvia DES was used to treat a flow limiting dissection after POBA of a long femoropopliteal CTO.
Thank you Kostas for this presentation. To answer one of your questions, I would always stent a CTO after subintimal recanalisation. What do you think?
In the majority of cases, indeed, we have to deploy a stent (bms or des) after subintimal recanalization. Nevertheless, adequate vessel prep might enable a leave nothing behind approach. Lesions calcification grad and length are also important parameters.